Use of randomised trials to decide when to monitor response to new treatment.

Bell, Katy J.L.; Irwig, Les; Craig, Jonathan C; Macaskill, Petra

Access status:

Open Access

Field	Value	Language
dc.contributor.author	Bell, Katy J.L.
dc.contributor.author	Irwig, Les
dc.contributor.author	Craig, Jonathan C
dc.contributor.author	Macaskill, Petra
dc.date.accessioned	2021-02-24T23:38:43Z
dc.date.available	2021-02-24T23:38:43Z
dc.date.issued	2008	en
dc.identifier.uri	https://hdl.handle.net/2123/24562
dc.description.abstract	Is monitoring initial response to treatment always helpful in clinical management of patients? Bell and colleagues have developed a framework for deciding whether surrogate outcomes should be used to monitor initial response to treatment in chronic disease.	en
dc.publisher	BMJ Publishing Group	en
dc.relation.ispartof	British Medical Journal	en
dc.rights	Copyright All Rights Reserved	en
dc.subject	hypertension	en
dc.subject	health outcomes	en
dc.subject	blood pressure	en
dc.subject	epidemiology	en
dc.subject	statistical	en
dc.subject	chronic disease	en
dc.title	Use of randomised trials to decide when to monitor response to new treatment.	en
dc.type	Article	en
dc.subject.asrc	1102 Cardiorespiratory Medicine and Haematology	en
dc.subject.asrc	1117 Public Health and Health Services	en
dc.identifier.doi	10.1136/bmj.39476.623611.25
dc.relation.nhmrc	402764
dc.rights.other	This article has been accepted for publication in BMJ 2008 following peer review, and the Version of Record can be accessed online at doi:10.1136/bmj.39476.623611.25	en
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Health	en
usyd.citation.volume	336	en
usyd.citation.issue	7640	en
usyd.citation.spage	361	en
usyd.citation.epage	365	en
workflow.metadata.only	No	en